Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Canine Syndecan-1 ELISA Kit (AC2568)
Cat.#: ASET-1157
Specifications
Description Canine Syndecan-1 ELISA Kit allows for the in vitro quantitative determination of canine Syndecan-1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Canine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1277 Rat BACE2 ELISA Kit (AC2688) Quantitative inquiry ASET-1785 Porcine C Peptide ELISA Kit (AC3196) Quantitative inquiry ASET-1188 Rat ERK1 ELISA Kit (AC2599) Quantitative inquiry ASET-2250 Rat PCDHB5 ELISA Kit (AC3661) Quantitative inquiry ASET-1969 Mouse HAS1 ELISA Kit (AC3380) Quantitative inquiry ASET-2076 Human EDG8 ELISA Kit (AC3487) Quantitative inquiry ASET-2461 Human GRIP1 ELISA Kit (AC3872) Quantitative inquiry ASET-1103 Mouse LC3B ELISA Kit (AC2514) Quantitative inquiry ASET-1980 Human Serine Racemase ELISA Kit (AC3391) Quantitative inquiry ASET-1532 Rat CaMKII beta ELISA Kit (AC2943) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket